SURMOUNT-1 Trial (72-Week Duration, 2,539 Participants): Average weight loss with 15 mg: 20.9% of body weight Participants losing 5%: 91% Participants losing 10%: 82% Participants losing 20%: 57% SURMOUNT-2 Trial (People with Type 2 Diabetes): Average weight loss with 15 mg: 15.7% A1C reduction: 2.0 percentage points Source: Jastreboff AM, et al
Instead, with proper treatment, it can stay at a low level that is easy to ignore
Blood 84, 1697
During the protocol, no lesion occurred on the injection area and the patient continued to use the drug in one injection per application in the following days without any reaction
The ability to help a significant proportion of patients with T2D achieve normoglycemia without an increased risk of hypoglycemia represents a paradigm shift, moving the therapeutic goal from mere control towards potential disease remission
Oxiglutatione disodium Glutathione oxidized disodium is produced by the oxidation of glutathione which is a major intracellular antioxidant and detoxifying agent
